Quince Therapeutics, Inc. Finance Lease, Liability, Noncurrent
Quince Therapeutics, Inc. (QNCX) had Finance Lease, Liability, Noncurrent of $19.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:FinanceLeaseLiabilityNoncurrent · last filed 2022-11-09
- 2022-09-30: Finance Lease, Liability, Noncurrent $19.00K.
- 2022-06-30: Finance Lease, Liability, Noncurrent $38.00K.
- 2021-12-31: Finance Lease, Liability, Noncurrent $0.00.
| Period end | Finance Lease, Liability, Noncurrent |
|---|---|
| 2022-09-30 | $19.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $38.00K 10-Q · filed 2022-08-09 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |